Rebound exercise
OtherRepeated jumping on a mini trampoline was administered
Other names: Mini trampoline rebounding
NCT Number: NCT02701569
The purpose of this study was to investigate the effect of rebound exercise (mini trampoline jumping) on metabolic outcomes and quality of life in patients with Type 2 Diabetes.
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Not applicable
The exercise involved jumping on the mini trampoline with feet slightly apart. Participants stood on the mid portion of the trampoline bed and made repeated up-and-down bouncy movements. Each foot strike equals one step or bounce. With each landing, the mat of the trampoline underwent deformation and the springs released the energy stored in them such that the participant was made to bounce off the mat. Exercise was administered for between 10 - 15 minutes after which a 5-minute period of rest was allowed. A heart rate monitor was used to guide the intensity of the exercise in the moderate range. Each participant accumulated between 20 and 30 minutes of rebound exercise (bouncing on a mini trampoline) per session, administered three times per week for 12 weeks. All data were captured at baseline and at the end of the 12-week intervention period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Repeated jumping on a mini trampoline was administered
Other names: Mini trampoline rebounding
Time frame: 3 months
Glycated hemoglobin was assessed using the mini-column ion-exchange chromatographic method and expressed in percentage
Time frame: 3 months
Fasting plasma glucose (in molar concentration) was measured by glucose oxidase assay using a glucose analyzer
Time frame: 3 months
Fasting insulin (in gravimetric unit) was determined using a commercially available ELISA human insulin kit
Time frame: 3 months
High-density lipoprotein cholesterol (in molar concentration) was enzymatically determined using commercial kits
Time frame: 3 months
Total cholesterol (in molar concentration) was enzymatically determined using commercial kits
Time frame: 3 months
Triglycerides (in molar concentration) were enzymatically determined using commercial kits
Time frame: 3 months
Low-density lipoprotein cholesterol (in molar concentration) was estimated using the Friedewald formula.
Time frame: 3 months
The short-form 36 health questionnaire was used to assess participants' quality of life and expressed in percentage
Time frame: 3 months
Body mass in kilograms was determined using a calibrated weighing scale
Time frame: 3 months
Height in meters was determined using a stadiometer
Time frame: 3 months
Heart rate was measured in beats per minute using a calibrated electronic device
Time frame: 3 months
Respiratory rate (in cycles per minute) was measured by observing and counting the number of times the chest rose in one minute
Time frame: 3 months
Blood pressure in millimeters of mercury (mmHg) was measured using a calibrated electronic device
Time frame: 3 months
Maximal oxygen consumption in milliliters per kilogram per minute (ml/kg/min) was obtained from exercise stress testing
Time frame: 3 months
Diabetes-related emotional distress was expressed in percentage
Time frame: 3 months
Participants' well-being was expressed in percentage
Time frame: 3 months
Score ranges from 0 (very dissatisfied) to 36 (very satisfied)
Time frame: 3 months
Score ranges from 0 to 63 with 0 to 13 being minimal and 29 to 63 being severe
University of KwaZulu
Other
Effect of Rebound Therapy on Metabolic Outcomes and Quality of Life in Nigerian Patients With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT06649344
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT07732218
Diabetes Mellitus, Diabetes Mellitus, Type 2
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial Details